NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
(University of California - San Diego) The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites and is led by Davey Smith, MD, of UC San Diego School of Medicine.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Azithromycin | Clinical Trials | COVID-19 | Hydroxychloroquine | Infectious Diseases | Malaria | Zithromax